As a science-based healthcare company, we strive to develop products that can change the practice of medicine. Novartis is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines.
Our global portfolio of innovative patented medicines includes more than 50 key marketed products, many of which are the leaders in their therapeutic areas.
Our Sandoz Division is a global leader in generic medicines and biosimilars, offering more than 1,000 different types of high-quality, affordable products across a broad range of therapeutic areas. It pioneers new ways to help people around the world access high quality medicines.